Out of the insulin-resistance mediating factors, plasminogen activator inhibitor-1 (PAI-1), MCP-1, IL-6, IL-8, IL-10 and tumour necrosis factor (TNF)-α were significantly elevated in these patients. This evidence concerns the gene CCL2 and Insulin resistance.